glp 1 for addiction treatment IUPHAR review – Glucagon-like peptide-1 (GLP-1) and substance use disorders: An emerging pharmacotherapeutic target GLP1 and Opioid Use Research

In addition to scarcity, GLP-1s have dethroned surgical weight loss

Efficacy and tolerability of tirzepatide, a dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist in patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled study to evaluate different dose-escalation regimens

Quick Answer: GLP-1 medications commonly alter bowel movements, causing either diarrhea or constipation in many patients, though individual responses vary significantly

Insulin and insulin secretagogues - Adding tirzepatide to insulin or insulin secretagogues (e.g., sulfonylureas, meglitinides) increases the risk of hypoglycemia

A story was emerging

It's both gluten-free and vegan, with less than 0.5% ABV, making it a great fit for GLP-1 dietary goals